← Evidence map

ArticleClinical hematology international2026

Should monitoring guidelines and decision to treat for I⁠gM MGUS be different when caring for Jehovah's Witness patients?

Marshall Rosenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Should monitoring guidelines and decision to treat for I⁠gM MGUS be different when caring for Jehovah's Witness patients? | OpenQuestion